Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000010980 | SCV002048168 | pathogenic | Hereditary factor VIII deficiency disease | 2020-12-18 | criteria provided, single submitter | clinical testing | The F8 c.5243; p.Arg1715Ter variant (rs137852439) is reported in the literature in multiple individuals affected with severe hemophilia A, including one individual in which the variant occurred de novo (see F8 database and references therein, Lu 2018). In vitro functional analyses demonstrate that individuals with this variant have factor VIII activity of <1% (see F8 database). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: F8 variant database: https://f8-db.eahad.org/ Lu Y et al. Spectrum and origin of mutations in sporadic cases of haemophilia A in China. Haemophilia. 2018 Mar;24(2):291-298. |
OMIM | RCV000010980 | SCV000031207 | pathogenic | Hereditary factor VIII deficiency disease | 1993-11-01 | no assertion criteria provided | literature only | |
Zotz- |
RCV000010980 | SCV004041804 | pathogenic | Hereditary factor VIII deficiency disease | 2023-10-09 | no assertion criteria provided | clinical testing |